TY - JOUR
T1 - Recommendations to drive a value-based decision-making on vaccination
AU - de Waure, C.
AU - Calabro, G. E.
AU - Ricciardi, Walter
PY - 2022
Y1 - 2022
N2 - Introduction: Health systems worldwide need to pay attention to both sustainability and quality. The explosion of health technologies represents a challenge for health systems’ sustainability, and evidence-based tools should support resources allocation to guarantee a continuous quality improvement. The value-based approach could disentangle the full benefit of a health technology, and this is of utmost importance in the vaccination field because of several obstacles still existing in reaching optimal vaccination uptake. Areas covered: The paper conveys the evidence on the full value of vaccine(s)/vaccination based on the framework suggested by the Expert Panel on Effective Ways of Investing in Health of the European Commission. Indeed, evidence on the personal, technical, allocative, and societal value of vaccine(s)/vaccination published in the last decade was described as foundation of a following consultation with international experts of the field. The result was the issuing of recommendations for research, decision-making, and public engagement that aimed to drive a value-based decision-making on vaccination. Expert opinion: The development of vaccination programs based on the recognition of the full value of vaccine(s)/vaccination is essential. To achieve this goal, it is necessary to launch intersectoral and multidisciplinary research and implementation initiatives involving all relevant stakeholders.
AB - Introduction: Health systems worldwide need to pay attention to both sustainability and quality. The explosion of health technologies represents a challenge for health systems’ sustainability, and evidence-based tools should support resources allocation to guarantee a continuous quality improvement. The value-based approach could disentangle the full benefit of a health technology, and this is of utmost importance in the vaccination field because of several obstacles still existing in reaching optimal vaccination uptake. Areas covered: The paper conveys the evidence on the full value of vaccine(s)/vaccination based on the framework suggested by the Expert Panel on Effective Ways of Investing in Health of the European Commission. Indeed, evidence on the personal, technical, allocative, and societal value of vaccine(s)/vaccination published in the last decade was described as foundation of a following consultation with international experts of the field. The result was the issuing of recommendations for research, decision-making, and public engagement that aimed to drive a value-based decision-making on vaccination. Expert opinion: The development of vaccination programs based on the recognition of the full value of vaccine(s)/vaccination is essential. To achieve this goal, it is necessary to launch intersectoral and multidisciplinary research and implementation initiatives involving all relevant stakeholders.
KW - Humans
KW - Immunization Programs
KW - Vaccination
KW - Vaccination policies
KW - Vaccines
KW - vaccines
KW - value
KW - value-based healthcare
KW - Humans
KW - Immunization Programs
KW - Vaccination
KW - Vaccination policies
KW - Vaccines
KW - vaccines
KW - value
KW - value-based healthcare
UR - https://publicatt.unicatt.it/handle/10807/201210
UR - https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85125552001&origin=inward
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85125552001&origin=inward
U2 - 10.1080/14760584.2022.2021880
DO - 10.1080/14760584.2022.2021880
M3 - Article
SN - 1476-0584
VL - 21
SP - 289
EP - 296
JO - Expert Review of Vaccines
JF - Expert Review of Vaccines
IS - 3
ER -